SCHEMBL842987

SCHEMBL842987

Cc1c(C(=O)O)ccc(-c2ccc(C(=O)O)cc2)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.49
CYP2C8 P10632 2/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
PTPN11 Q06124 1/20 0.43
SRD5A2 P31213 2/20 0.42
BCL2L1 Q07817 1/20 0.42
BAD Q92934 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28376237 0.90 ALDH1A1 (0.56) FOLH1CYP2C8RXRARXRBSMN1; SMN2
Terephthalic Acid SCHEMBL3694747 0.86 ALDH1A1 (0.61) RXRARXRBSMN1; SMN2ALDH1A1TP53
SCHEMBL28503156 0.85 EGFR (0.52) SMN1; SMN2ALDH1A1TSHRNPC1RAB9A
SCHEMBL6974190 0.85 ALDH1A1 (0.49) FOLH1SMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL27547124 0.84 KDM4E (0.43) SMN1; SMN2ALDH1A1HSD17B10MYC
SCHEMBL843489 0.82 CYP1A2 (0.48) SMN1; SMN2ALDH1A1TSHRHSD17B10MYC
SCHEMBL11516942 0.80 CSNK2A2 (0.52) NR1H4
SCHEMBL11517521 0.80 HSD11B1 (0.43) FOLH1CYP2C8RXRARXRBPTPN11
SCHEMBL28545722 0.80 GRIK1 (0.46) RXRARXRBALDH1A1
SCHEMBL9599411 0.80 FOLH1 (0.55) FOLH1RXRARXRBPTPN11MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118341280-A Separation membrane for purifying carbohydrate auxiliary material, and preparation method and application thereof 上海沃凯生物技术有限公司 2024-07-16 CN claimed
EP-4076734-B1 COMPOSITE MATERIAL COMBINING MOF NANOPARTICLES AND METAL NANOPARTICLES CENTRE NAT RECH SCIENT (FR) 2024-04-03 EP claimed
EP-4076734-A1 COMPOSITE MATERIAL COMBINING MOF NANOPARTICLES AND METAL NANOPARTICLES Centre national de la recherche scientifique (FR) 2022-10-26 EP claimed
US-11426704-B2 Metal organic frameworks for the capture of volatile organic compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-08-30 US claimed
US-20210277042-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES UNIVERSITÉ DE VERSAILLES - SAINT-QUENTIN-EN-YVELINES (FR) 2021-09-09 US claimed
EP-3453450-B1 USE OF METAL ORGANIC FRAMEWORKS FOR THE CAPTURE OF ACETIC ACID CENTRE NAT RECH SCIENT (FR) 2021-06-30 EP claimed
WO-2021123570-A1 COMPOSITE MATERIAL COMBINING MOF NANOPARTICLES AND METAL NANOPARTICLES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-24 WO claimed
US-11034711-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-15 US claimed
US-20200269211-A1 METAL ORGANIC FRAMEWORKS FOR THE CAPTURE OF VOLATIL ORGANIC COMPOUNDS ÉCOLE SUPÉRIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS (FR) 2020-08-27 US claimed
EP-3681627-A1 METAL ORGANIC FRAMEWORKS FOR THE CAPTURE OF VOLATIL ORGANIC COMPOUNDS Centre National De La Recherche Scientifique (FR) 2020-07-22 EP claimed
EP-2260048-B1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP claimed
EP-2376503-A1 METHOD FOR HYDROTHERMAL PREPARATION OF METAL-ORGANIC FRAMEWORK CRYSTALLISED POROUS ALUMINIUM CARBOXYLATES Centre National de la Recherche Scientifique - CNRS - (FR) 2011-10-19 EP claimed
US-20110172412-A1 REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS UNIVERSITE DE CAEN-BASSE NORMANDIE (FR) 2011-07-14 US claimed
US-20110052650-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST Centre National De La Recherche Scientifique - CNR S (FR) 2011-03-03 US claimed
EP-2260048-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST Centre National de la Recherche Scientifique - CNRS (FR) 2010-12-15 EP claimed
WO-2010136677-A1 USE OF A POROUS CRYSTALLINE HYBRID SOLID AS A NITROGEN OXIDE REDUCTION CATALYST AND DEVICES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS (FR) 2010-12-02 WO claimed
US-20100226991-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS- (FR) 2010-09-09 US claimed
US-20100209354-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2010-08-19 US claimed
WO-2010058123-A1 METHOD FOR HYDROTHERMAL PREPARATION OF METAL-ORGANIC FRAMEWORK CRYSTALLISED POROUS ALUMINIUM CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS- (FR) 2010-05-27 WO claimed
WO-2009133278-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-11-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110052650-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST MITF, SLCO2B1, SLCO2A1 FOLH1 717/4885CYP2C8 1601/4885RXRA 1691/4885
US-20100226991-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE SLCO2A1, SLCO4C1, SLCO2B1 FOLH1 1271/4885CYP2C8 928/4885RXRA 968/4885
US-20210277042-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES FTO, TPI1, ACP1 FOLH1 594/4885CYP2C8 3152/4885RXRA 4670/4885
US-20110172412-A1 REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS SORBS1, MRPS23, CTCF FOLH1 1084/4885CYP2C8 3319/4885RXRA 1250/4885
US-20100209354-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES SLC39A3, SLC40A1, AOC3 FOLH1 381/4885CYP2C8 2288/4885RXRA 3552/4885
US-11034711-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles FTO, TPI1, ACP1 FOLH1 594/4885CYP2C8 3152/4885RXRA 4670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.